← Open Payments lookup

MADIHA GHAYAS: Open Payments

NPI 1609199926 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$637 in 28 payments from 14 companies in 2025. Trend: 2023 $1,582 · 2024 $1,293 · 2025 $637

Food & beverage: $637
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$156
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$99
Corium, LLC3$64
Otsuka America Pharmaceutical, Inc.3$55
Bausch Health US, LLC2$53
ABBVIE INC.2$45
Tris Pharma Inc2$37
Lundbeck LLC1$31
Alkermes, Inc.1$19
Takeda Pharmaceuticals U.S.A., Inc.1$18

Products named: INGREZZA, CAPLYTA, REXULTI, Azstarys, APLENZIN, VRAYLAR, Dyanavel XR, ARISTADA.

Industry payments across TX — which companies pay providers there.